RVL Pharmaceuticals plc Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
RVL Pharmaceuticals plc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q2 2023.
  • RVL Pharmaceuticals plc Common Stock, Shares, Outstanding for the quarter ending June 30, 2023 was 99.4M shares, a 18.9% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 99.4M +15.8M +18.9% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 99.3M +15.8M +19% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 99.2M +15.9M +19% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 99.2M +36M +57.1% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 83.6M +20.8M +33% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 83.5M +20.8M +33.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 83.3M +20.8M +33.2% Dec 31, 2021 10-K 2023-03-20
Q3 2021 63.1M +21.5K +0.03% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 62.8M +4.09M +6.96% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 62.7M +3.82M +6.49% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 62.5M +10.7M +20.6% Dec 31, 2020 10-K 2022-03-30
Q3 2020 63.1M +10.9M +21% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 58.8M +6.24M +11.9% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 58.9M +6.38M +12.1% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 51.8M -673K -1.28% Dec 31, 2019 8-K 2021-09-08
Q3 2019 52.2M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 52.5M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 52.5M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 52.5M Dec 31, 2018 10-K 2020-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.